Clinical trial · Interventional
MiniFlo for Advanced Dupuytren's Disease
Treatment of Stage III-IV Dupuytren's Disease With the MiniFlo External Fixator
NCT07505563CI-TRIAL-00107005completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this study is to investigate the potential use of the MiniFlo (CitiEffe) progressive distraction external fixator in the treatment of advanced Dupuytren's disease.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Dupuytren's Disease | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| MiniFlo | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Advanced-stage Dupuytren's disease
- description
- Stage 3-4 Dupuytren's disease
- interventionNames
- Device: MiniFlo
Primary outcomes (1)
- measure
- Extension deficit angle (degree)
- timeFrame
- 12 months
- description
- Evaluation of extension deficit angle of fingers affected before and after the treatment. Min 0° (no deficit), Max 180° (high stage disease)
Secondary outcomes (2)
- measure
- Collagenase adverse effects
- timeFrame
- 12 months
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Dupuytren's disease * Age ≥ 18 years * Informed consent Exclusion Criteria: * Age \< 18 years * Pregnancy * Withdrawal of informed consent
References
Publications (0)
Data not yet available
No reference posted for this study.